Form 4: Okta Director Jacques Kerrest Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Director Jacques Kerrest sold Okta shares worth approximately $287,000 under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On January 21, 2025, Jacques Frederic Kerrest, a director at Okta, Inc., sold 1,936 shares of Class A Common Stock at a weighted average price of $88.5481 and 1,370 shares at a weighted average price of $89.2731.
- The sales were executed under a Rule 10b5-1 trading plan adopted on September 19, 2024.
- Following the transactions, Kerrest directly owns 0 shares of Class A Common Stock.
- Kerrest also holds derivative securities, including options to purchase Class A and B Common Stock, and Restricted Stock Units (RSUs) representing the right to receive Class A Common Stock.
- Kerrest indirectly owns 1,139,387 shares of Class A Common Stock by Trust, 129,376 shares of Class A Common Stock by Trust and 257,668 shares of Class A Common Stock by Trust.
Sentiment
Score: 5
Explanation: Neutral sentiment. The filing simply reports stock sales under a pre-arranged plan. There's no inherent positive or negative signal, but the market's interpretation can vary.
Negatives
- The director's sale of shares, even under a pre-arranged plan, could be perceived negatively by some investors.
Risks
- Further sales by insiders could put downward pressure on the stock price.
Industry Context
Insider sales are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares without being accused of acting on non-public information. The market will often look at the size and frequency of these sales to gauge insider sentiment.
Comparison to Industry Standards
- Comparing Kerrest's transactions to other directors in similar SaaS companies would provide a better understanding of whether these sales are typical.
- Analyzing the percentage of Kerrest's holdings sold relative to his total stake in Okta would also be informative.
- Comparing the timing of the 10b5-1 plan adoption to other insider sales at Okta could reveal patterns or trends.
Stakeholder Impact
- The stock sale could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 09/19/2024 | Date the Reporting Person adopted the Rule 10b5-1 trading plan |
| 01/21/2025 | Date of the reported transactions (stock sales) |
| 06/20/2025 | Date Restricted Stock Units (RSUs) vest in full |
| 07/29/2026 | Employee Stock Option (Right to Buy) Expiration Date |
| 03/21/2028 | Employee Stock Option (Right to Buy) Expiration Date |
| 03/24/2029 | Employee Stock Option (Right to Buy) Expiration Date |
| 04/14/2030 | Employee Stock Option (Right to Buy) Expiration Date |
| 04/21/2031 | Employee Stock Option (Right to Buy) Expiration Date |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.